Literature DB >> 20935475

LATS tumor suppressor: a new governor of cellular homeostasis.

Stacy Visser1, Xiaolong Yang.   

Abstract

Accumulating evidence points to the LATS (Large Tumor Suppressor) family of human tumor suppressors (LATS1 and LATS2) as new resident governors of cellular homeostasis. Loss of function of either LATS1 or LATS2 leads to a variety of tumor types including soft tissue sarcomas, leukemia, as well as breast, prostate, lung and esophageal cancers. Due to their high degree of homology and functional overlap, LATS1 and LATS2 comprise a new tumor suppressor family. Classically identified within the Hippo-LATS signaling pathway, LATS also acts independently of this pathway, possessing multiple functions including regulation of cell proliferation, cell death and cell migration, as well as broad governing roles such as transcriptional regulation and maintenance of genetic stability. Activity of LATS is tightly controlled through various mechanisms including post-translational modifications, differential localization and expression. Although little is known about the specific underlying mechanisms of these activities, current data suggest that LATS signaling intersects with well-established tumor suppressive or oncogenic pathways including the p53, Ras or Akt networks. This review aims to identify what we know about the LATS tumor suppressor family, highlighting LATS1 and LATS2 redundancies and differences in terms of their structure, expression, regulation and functions, thereby establishing a novel tumor suppressor network.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935475     DOI: 10.4161/cc.9.19.13386

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  111 in total

1.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

2.  Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation.

Authors:  Kun Zhang; Eva Rodriguez-Aznar; Norikazu Yabuta; Robert J Owen; Jose M Mingot; Hiroshi Nojima; M Angela Nieto; Gregory D Longmore
Journal:  EMBO J       Date:  2011-09-27       Impact factor: 11.598

3.  Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.

Authors:  Xu-Yong Lin; Xiu-Peng Zhang; Jun-Hua Wu; Xue-Shan Qiu; En-Hua Wang
Journal:  Tumour Biol       Date:  2014-03-29

4.  NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.

Authors:  Zaidoun Salah; Sherri Cohen; Ella Itzhaki; Rami I Aqeilan
Journal:  Cell Cycle       Date:  2013-10-07       Impact factor: 4.534

5.  Hippo signaling: to die or not to die.

Authors:  R I Aqeilan
Journal:  Cell Death Differ       Date:  2013-10       Impact factor: 15.828

6.  Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.

Authors:  Mingde Huang; Jiakai Hou; Yunfei Wang; Min Xie; Chenchen Wei; Fengqi Nie; Zhaoxia Wang; Ming Sun
Journal:  Mol Ther       Date:  2017-02-15       Impact factor: 11.454

Review 7.  Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.

Authors:  J Wang; J F Martin
Journal:  J Dent Res       Date:  2017-07-12       Impact factor: 6.116

8.  LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer.

Authors:  Saki Matsui; Naofumi Kagara; Chieko Mishima; Yasuto Naoi; Masafumi Shimoda; Atsushi Shimomura; Kenzo Shimazu; Seung Jin Kim; Shinzaburo Noguchi
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

9.  Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

Authors:  Pinelopi Nterma; Eleni Panopoulou; Eleni Papadaki-Petrou; Martha Assimakopoulou
Journal:  Pathol Oncol Res       Date:  2019-01-02       Impact factor: 3.201

10.  Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor.

Authors:  Taha Azad; Kazem Nouri; Helena J Janse van Rensburg; Yawei Hao; Xiaolong Yang
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.